skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 183,401  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Material Type:
Article
Add to My Research

Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups

Nature (London), 2019-03, Vol.567 (7748), p.399-404 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Mar 21, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1007-8 ;PMID: 30867590

Full text available

2
Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society
Material Type:
Article
Add to My Research

Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society

Journal of gastroenterology, 2020-01, Vol.55 (1), p.86-99 [Peer Reviewed Journal]

Japanese Society of Gastroenterology 2019 ;COPYRIGHT 2020 Springer ;Journal of Gastroenterology is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0944-1174 ;EISSN: 1435-5922 ;DOI: 10.1007/s00535-019-01617-2 ;PMID: 31463655

Full text available

3
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence
Material Type:
Article
Add to My Research

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

Clinical cancer research, 2019-07, Vol.25 (14), p.4255-4263 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-18-3663 ;PMID: 30992300

Full text available

4
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Material Type:
Article
Add to My Research

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

JNCI : Journal of the National Cancer Institute, 2018-06, Vol.110 (6), p.560-567 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djy018 ;PMID: 29659933

Full text available

5
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
Material Type:
Article
Add to My Research

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2019-12, Vol.25 (24), p.7448-7454 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-1050 ;PMID: 31511295

Full text available

6
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Material Type:
Article
Add to My Research

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

The lancet oncology, 2013-11, Vol.14 (12), p.1200-1207 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2013 ;2013 Elsevier Ltd. All rights reserved 2013 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70449-2 ;PMID: 24140199 ;CODEN: LANCAO

Full text available

7
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
Material Type:
Article
Add to My Research

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

The lancet oncology, 2016-06, Vol.17 (6), p.738-746 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)00150-9 ;PMID: 27108243 ;CODEN: LANCAO

Full text available

8
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Material Type:
Article
Add to My Research

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

The lancet oncology, 2021-04, Vol.22 (4), p.450-462 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30737-3 ;PMID: 33794205

Full text available

9
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Material Type:
Article
Add to My Research

Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies

CA: a cancer journal for clinicians, 2018-11, Vol.68 (6), p.488-505 [Peer Reviewed Journal]

2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21498 ;PMID: 30328620

Full text available

10
From normal response to clinical problem: definition and clinical features of fear of cancer recurrence
Material Type:
Article
Add to My Research

From normal response to clinical problem: definition and clinical features of fear of cancer recurrence

Supportive care in cancer, 2016-08, Vol.24 (8), p.3265-3268 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2016 ;COPYRIGHT 2016 Springer ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-016-3272-5 ;PMID: 27169703

Full text available

11
Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer
Material Type:
Article
Add to My Research

Evaluation of serum exosomal LncRNA‐based biomarker panel for diagnosis and recurrence prediction of bladder cancer

Journal of cellular and molecular medicine, 2019-02, Vol.23 (2), p.1396-1405 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14042 ;PMID: 30467945

Full text available

12
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Material Type:
Article
Add to My Research

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Immunity (Cambridge, Mass.), 2013-10, Vol.39 (4), p.782-795 [Peer Reviewed Journal]

2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 17, 2013 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2013.10.003 ;PMID: 24138885

Full text available

13
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
Material Type:
Article
Add to My Research

Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Nature medicine, 2021-02, Vol.27 (2), p.301-309 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-01188-3 ;PMID: 33558722

Full text available

14
Hepatocellular carcinoma: clinical frontiers and perspectives
Material Type:
Article
Add to My Research

Hepatocellular carcinoma: clinical frontiers and perspectives

Gut, 2014-05, Vol.63 (5), p.844-855 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2013-306627 ;PMID: 24531850 ;CODEN: GUTTAK

Full text available

15
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Material Type:
Article
Add to My Research

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical cancer research, 2021-02, Vol.27 (4), p.1048-1057 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-2500 ;PMID: 33199490

Full text available

16
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Material Type:
Article
Add to My Research

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv19-iv29 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy080 ;PMID: 29796651

Full text available

17
Overcoming therapeutic resistance in glioblastoma: the way forward
Material Type:
Article
Add to My Research

Overcoming therapeutic resistance in glioblastoma: the way forward

The Journal of clinical investigation, 2017-02, Vol.127 (2), p.415-426 [Peer Reviewed Journal]

COPYRIGHT 2017 American Society for Clinical Investigation ;COPYRIGHT 2017 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Feb 2017 ;Copyright © 2017, American Society for Clinical Investigation 2017 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci89587 ;PMID: 28145904

Full text available

18
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Material Type:
Article
Add to My Research

Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

Annals of oncology, 2019-11, Vol.30 (11), p.1804-1812 [Peer Reviewed Journal]

2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz390 ;PMID: 31562764

Full text available

19
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
Material Type:
Article
Add to My Research

Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response

Blood, 2017-08, Vol.130 (6), p.732-741 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-04-779447 ;PMID: 28588019

Full text available

20
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
Material Type:
Article
Add to My Research

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

J. Hepatol, 2019-01, Vol.70 (1), p.58-65 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;DOI: 10.1016/j.jhep.2018.09.003 ;PMID: 30213589

Digital Resources/Online E-Resources

Results 1 - 20 of 183,401  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (165,361)

Refine My Results

Creation Date 

From To
  1. Before 1961  (402)
  2. 1961 To 1976  (3,583)
  3. 1977 To 1992  (20,487)
  4. 1993 To 2009  (66,045)
  5. After 2009  (92,579)
  6. More options open sub menu

Subject 

  1. Humans  (156,298)
  2. Science & Technology  (147,861)
  3. Life Sciences & Biomedicine  (142,059)
  4. Recurrence  (109,239)
  5. Female  (103,664)
  6. Male  (93,532)
  7. Middle Aged  (77,447)
  8. Adult  (68,262)
  9. Aged  (58,570)
  10. Biological And Medical Sciences  (44,155)
  11. Medical Sciences  (43,647)
  12. Oncology  (37,062)
  13. Surgery  (35,361)
  14. Treatment Outcome  (35,263)
  15. Retrospective Studies  (30,683)
  16. Follow-Up Studies  (29,341)
  17. Prognosis  (27,746)
  18. Adolescent  (23,376)
  19. Risk Factors  (21,537)
  20. Neoplasm Recurrence, Local  (21,300)
  21. More options open sub menu

Language 

  1. English  (174,948)
  2. Japanese  (23,817)
  3. German  (2,638)
  4. French  (1,944)
  5. Spanish  (1,785)
  6. Portuguese  (1,450)
  7. Korean  (582)
  8. Chinese  (573)
  9. Russian  (279)
  10. Polish  (217)
  11. Norwegian  (197)
  12. Turkish  (193)
  13. Italian  (143)
  14. Swedish  (114)
  15. Czech  (64)
  16. Serbian  (62)
  17. Persian  (50)
  18. Ukrainian  (43)
  19. Croatian  (41)
  20. Catalan  (17)
  21. More options open sub menu

Searching Remote Databases, Please Wait